MedTrace Logo

Evaluation of Reporting of Road Traffic Accidents With Drugs Responsible for Cognitive Side Effects (ERoADS)

NCT04480996 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2020-07-22

No results posted yet for this study

Summary

Drugs responsible for cognitive and psychomotor side effects may lead to impaired driving skills and road traffic accidents. This study investigates reports of road traffic accident for different class of drugs responsible for cognitive and psychomotor sides effects (pyschotropic agents, neurotropic agents, antineoplasic agents) in the World Health Organization's (WHO) global database of individual safety case reports (VigiBase).

Conditions

  • Accident, Traffic

Interventions

DRUG

Drugs Responsible for Cognitive Side Effects

identification of road traffic accidents associated with drugs responsible for psychomotor side effects

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Véronique Lelong-Boulouard, PhD, PharmD · CHU CAEN

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-12-01
Completion
2023-06-01
FDA Drug
Yes

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04480996 on ClinicalTrials.gov